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Abstract
Background: In combination with gene expression profiles, the protein interaction network (PIN) constructs a
dynamic network that includes multiple functional modules. Previous studies have demonstrated that rifampin
can influence drug metabolism by regulating drug-metabolizing enzymes, transporters, and microRNAs (miRNAs).
Rifampin induces gene expression, at least in part, by activating the pregnane X receptor (PXR), which induces
gene expression; however, the impact of rifampin on global gene regulation has not been examined under the
molecular network frameworks.
Methods: In this study, we extracted rifampin-induced significant differentially expressed genes (SDG) based on the
gene expression profile. By integrating the SDG and human protein interaction network (HPIN), we constructed the
rifampin-regulated protein interaction network (RrPIN). Based on gene expression measurements, we extracted a
subnetwork that showed enriched changes in molecular activity. Using the Kyoto Encyclopedia of Genes and Genomes
(KEGG), we identified the crucial rifampin-regulated biological pathways and associated genes. In addition, genes
targeted by miRNAs that were significantly differentially expressed in the miRNA expression profile were extracted
based on the miRNA-gene prediction tools. The miRNA-regulated PIN was further constructed using associated genes
and miRNAs. For each miRNA, we further evaluated the potential impact by the gene interaction network using
pathway analysis.
Results and Disccussion: We extracted the functional modules, which included 84 genes and 89 interactions, from
the RrPIN, and identified 19 key rifampin-response genes that are associated with seven function pathways that include
drug response and metabolism, and cancer pathways; many of the pathways were supported by previous studies. In
addition, we identified that a set of 6 genes (CAV1, CREBBP, SMAD3, TRAF2, KBKG, and THBS1) functioning as gene hubs
in the subnetworks that are regulated by rifampin. It is also suggested that 12 differentially expressed miRNAs were
associated with 6 biological pathways.
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Conclusions: Our results suggest that rifampin contributes to changes in the expression of genes by regulating key
molecules in the protein interaction networks. This study offers valuable insights into rifampin-induced biological
mechanisms at the level of miRNAs, genes and proteins.
Background
Protein-protein interactions are intrinsic to most bio-
logical processes [1]. Expanded knowledge of the protein
interaction network (PIN) may shed light on basic cellular
mechanisms. An expression profile is a dynamic collection
of data used to deduce a gene’s function, state, environ-
ment, etc. With the increasing availability of genome and
proteome data, the PIN can be integrated with gene ex-
pression profiles to create conditional network modules
within a specific biological state. This method has
been used to explore cellular mechanisms associated
with multiple diseases [2], including cancer. For instance,
Zhang et al. [3] analysed the genes and crucial modules
associated with coronary artery diseases (CAD), and sug-
gested that two proteins were critical for the development
of CAD. Lin et al. [2] studied dynamic functional modules
and co-expressed protein interaction networks in cases
of dilated cardiomyopathy. Previous studies suggest that
the integrated analysis of PIN and gene expression pro-
file information may contribute to the identification of
the functional modules and key genes that are relevant
to important biological pathways.
Rifampin is a drug that is usually used to treat tu-
berculosis and inactive meningitis [4]. The molecular
mechanisms and functions of rifampin-regulation have
previously been identified. Our previous study has con-
firmed that rifampin altered expression level of miRNAs
and many cytochrome P450 enzymes (CYPs), which are
the major metabolic enzymes that control the metabolism
of most clinically important drugs, and some of the
changes exist in associated relationships that suggest
that some of CYP mRNAs are targeted by some miR-
NAs [5–8]. Rifampin is also a typical ligand of the preg-
nane X receptor (PXR), which is a transcription factor
and a key regulator of the CYPs and other genes in-
volved in drug disposition [9, 10]. Furthermore, rifam-
pin can rapidly downregulate hepatic angiogenesis- and
mitogenesis-related genes. Therefore, it shows favorable
antiproliferative effects on endothelial cell, which is
make it potentially beneficial for targeting hepatobiliary
cancer cells [11, 12].
Previous studies have demonstrated that the drug-
metabolizing enzymes [6], transporters, and microRNAs
(miRNAs) are regulated by rifampin [11, 12], and the
mechanisms of the regulation of some of these genes
are well-studied; however, little has been done to put
the global gene expression effects of rifampin into
biological pathways and interactive networks. Protein
interaction network can depict and integrate information
pertaining to domain architecture, post-translational
modification, interaction networks and disease association
for each protein in the human proteome [13]. Further-
more, by combining with mRNA expression profiles,
they can be used to identify specific correlations of
between the genes, and to identify the key genes and
functional modules associated with critical biological
pathways. In addition, the integration of the miRNA
expression profiles can depict relationship between
the altered expression of miRNAs and their targeted-
mRNA. The implementation of an integrative method that
incorporates protein interaction networks and gene
expression profiles to reveal conditional network modules
associated with the rifampin-regulated biological pro-
cesses becomes increasingly important in clarifying the
regulatory mechanisms responsible for the rifampin
effects on gene expression.
In this study, we focused on identifying the key genes,
miRNAs, and the regulatory relationships among them.
We also explored the rifampin-induced biological path-
ways by integrating the protein interaction networks and
the miRNA and mRNA expression profiles. In this study,
we propose a method which can be used to identify the
rifampin-regulated functional modules in the protein
interaction network of human hepatocytes, and can also
be used to further analyze the rifampin-induced miRNAs
and their functions. A schematic of the overall method is
illustrated in Fig. 1. In this model, the gene expression
profile and PIN are integrated to construct the rifampin-
regulated protein interaction network (RrPIN). Then, in
order to analyse the crucial biological pathways, we iden-
tify the functional modules that participate in a common
biological function within the protein-protein interaction
network. Next, the functional modules are extracted using
BioNet and jActiveModules, and the rifampin-induced
significant differentially expressed key genes are identified
based on an analysis of Gene Ontology (GO) and the
Kyoto Encyclopedia of Genes and Genomes (KEGG). Fi-
nally, the miRNA-regulated PINs are established using
these key genes and gene-targeted miRNAs based on the
miRNA expression profile and miRNA-target prediction
databases, and the functions of the miRNAs are revealed
based on GO and KEGG. The proposed analysis enables
us to uncover rifampin-induced biological mechanisms in
human hepatocytes.
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Methods
Data
The gene expression dataset and miRNA expression
dataset were performed as our previous study in Rama-
moorthy et al. [8]. In the current study, the miRNA and
mRNA expression profiles were obtained from primary
human hepatocyte cultures (obtained from CellzDirect)
from 7 donors, each treated with rifampin or vehicle for
a total of 14 datasets. Cultures from each subject were
treated as biologic replicates (n = 7). The hepatocytes
were treated with rifampin or vehicle for 24 h and the
total RNAs were isolated using a miRNeasy kit. The
mRNA expression profile included 12,780 genes. The
miRNA expression profile, which included 334 miRNAs,
was measured using the Taqman OpenArray Human
miRNA Panel using a NT Cycler. The mRNAs expres-
sion was measured using a standard method including
EZBead preparation, Next-Gene sequencing, read quality
assessment, sequence alignment, and RNA-Seq differen-
tial expression analysis.
Construction of RrPIN
The PPI data was downloaded from the Human Protein
Reference Database (HPRD) [13], which contains experi-
mentally validated interactions within the human prote-
ome. The human liver protein interaction network (HLPN)
[14] contains proteome-scale protein interaction maps of
the human liver. It is comprised of 3484 interactions
Fig. 1 The hierarchical chart of identification of rifampin-regulated functional modules and related miRNAs
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among 2582 proteins and provides substantial new insights
into systems biology, disease research, and drug discovery.
To construct the human protein interaction network
(HPIN), all the proteins and non-overlapped interactions
in the HPLN and HPRD were merged as the nodes and in-
teractions of HPIN.
To construct the rifampin-regulated gene network, we
integrated the gene expression profile and HPIN as follows:
the SDGs which were included in the HPIN were used as
RrPIN’s nodes, and the interactions of RrPIN’s nodes in the
HPIN were used as the RrPIN’s interactions. Cytoscape ver-
sion 3.0.2 software (http://chianti.ucsd.edu/cytoscape-3.2.0/)
[15] was used to generate the network.
Identification of the functional modules
Particular interest of BioNet and jActiveModules were
the identification of functional modules in the network
in which the nodes have significant P-values by means of
detecting differentially expressed regions in networks.
This indicates a group of nodes which are densely con-
nected and have significant differences in expression level,
suggesting a module whose activity is influenced by the
experimental context of the expression data. The func-
tional modules tend to correspond to shared common
cellular function beyond the scope of classical pathways
[16–18]. The maximally scoring optimal module was
identified using BioNet [17, 18]. And the jActiveModules
plug-in of cytoscape was used to further identify multiple
significant modules in the PPI network [16].
Enrichment analysis of functional modules
The gene-annotation enrichment analysis was performed
using the Database for Annotation, Visualization,
and Integrated Discovery (DAVID), which provides a
Fig. 2 The workflow of the RrPIN. Color is according to the fold change where red denotes upregulated and green denotes downregulated
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comprehensive set of functional annotation tools for
biological interpretation of large gene lists. GO and KEGG
are included in the set of functional annotation tools
of DAVID. To study the rifampin-regulated biological
process, we used DAVID’s GOTERM_BP_FAT (lower levels
of biological process ontology), and KEGG pathway
analysis to identify enriched biological themes, particu-
larly GO terms [19].
Fig. 3 The functional modules of RrPIN. a The maximally functional module of PPI network. Color is according to the fold change where red
denotes upregulated and green denotes downregulated. The shape of the nodes depicts the aggregate score: circles indicate a negative score,
rectangles denotes a positive score. b, c, d, e and f are the five functional modules of RrPIN. The regulatory relationships are denoted by colours
in which red indicates upregulated genes, and green indicates downregulated. As well, the depth of the colour explains the size of fold change
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Identification of miRNAs and analysis of their functions
MiRNAs with p < 0.05 were regarded as significant dif-
ferentially expressed miRNAs. We identified these miR-
NAs’ target genes using the R library RmiR.Hs.miRNA
[20] which collects information from different miRNA
target databases. In this study, Targetscan [21, 22], mi-
Randa [23], PicTar [24] and miRTarBase [25, 26] were
choosen. The BiomaRt [27] library, which provides a
wide range of online queries from gene annotation to
database mining, was used to convert gene IDs to gene
symbols based on the hsapiens_gene_ensembl database.
For each miRNA, the miRNA-targeted genes belonging to
functional modules were considered as the nodes of the
miRNA-regulated PIN. The interactions of these genes in
PPI and of each miRNA with its target genes were consid-
ered as the interactions of the miRNA-regulated PIN. As a
result, we obtained the miRNA-regulated PIN. For each
miRNA, we analysed its potential functions by analysing
the miRNA’s target genes based on GO and KEGG.
Results
SDGs and RrPIN
The mRNA expression profile was obtained from RNA-
seq data from primary hepatocytes from 7 subjects treated
with rifampin or vehicle. In order to focus on cellular re-
sponses that are triggered by the rifampin treatment, we
pre-selected the genes that are differentially expressed
with a loose p-value threshold at p-value < 0.01 without
multiple hypothesis correction. Our further analysis
focuses on 1866 differentially expressed genes that pass
the threshold. We mapped all the differentially expressed
genes on the combined human protein interaction network,
Table 1 Table of top 20 GO terms and top 10 KEGG terms for the genes of functional modules
Category Term Count Percent P-value Benjiamini
GOTERM_BP_FAT regulation of apoptosis 19 22.6 5.10E-07 7.30E-04
GOTERM_BP_FAT regulation of programme cell death 19 22.6 5.90E-07 4.20E-04
GOTERM_BP_FAT regulation of cell death 19 22.6 6.20E-07 3.00E-04
GOTERM_BP_FAT negative regulation of apoptosis 13 15.5 7.90E-07 2.80E-04
GOTERM_BP_FAT negative regulation of programmed cell death 13 15.5 9.10E-07 2.60E-04
GOTERM_BP_FAT negative regulation of cell death 13 15.5 9.40E-07 2.20E-04
GOTERM_BP_FAT membrane organization 13 15.5 1.70E-06 3.50E-04
GOTERM_BP_FAT vesicle-mediated transport 15 17.9 4.50E-06 8.10E-04
GOTERM_BP_FAT membrane invagination 10 11.9 4.70E-06 7.40E-04
GOTERM_BP_FAT endocytosis 10 11.9 4.70E-06 7.40E-04
GOTERM_BP_FAT response to hypoxia 8 9.5 1.20E-05 1.70E-03
GOTERM_BP_FAT response to oxygen levels 8 9.5 1.60E-05 2.10E-03
GOTERM_BP_FAT response to inorganic substance 9 10.7 2.30E-05 2.70E-03
GOTERM_BP_FAT anti-apoptosis 9 10.7 2.40E-05 2.60E-03
GOTERM_BP_FAT positive regulation of multicellular organismal process 9 10.7 7.90E-05 8.00E-03
GOTERM_BP_FAT drug metabolic process 4 4.8 9.80E-05 9.20E-03
GOTERM_BP_FAT response to metal ion 7 8.3 9.80E-05 8.70E-03
GOTERM_BP_FAT phagocytosis 5 6 1.60E-04 1.40E-02
GOTERM_BP_FAT response to organic substance 14 16.7 2.20E-04 1.80E-02
GOTERM_BP_FAT regulation of tube size 5 6 2.40E-04 1.80E-02
KEGG_PATHWAY Metabolism of xenobiotics by cytochrome P450 6 7.1 2.00E-04 1.70E-02
KEGG_PATHWAY Retinol metabolism 5 6 1.40E-03 6.00E-02
KEGG_PATHWAY Drug metabolism 5 6 2.40E-03 6.70E-02
KEGG_PATHWAY Linoleic acid metabolism 3 3.6 2.70E-02 4.50E-01
KEGG_PATHWAY Pathways in cancer 8 9.5 2.90E-02 4.00E-01
KEGG_PATHWAY Focal adhesion 6 7.1 3.70E-02 4.10E-01
KEGG_PATHWAY Porphyrin and chlorophyll metabolism 3 3.6 3.70E-02 3.70E-01
KEGG_PATHWAY Small cell lung cancer 4 4.8 4.20E-02 3.70E-01
KEGG_PATHWAY ECM-receptor interaction 4 4.8 4.20E-02 3.70E-01
KEGG_PATHWAY TGF-beta signaling pathway 4 4.8 4.60E-02 3.60E-01
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which consists of 10,210 proteins with 42,521 interactions.
As shown in Fig. 2, the resultant rifampin interaction
network includes 663 proteins with 1024 interactions.
Identification and analysis of the functional modules
The aforementioned network contains candidate differ-
entially expressed genes with a flexible p-value cutoff.
This is intentional since our network analysis will be fur-
ther used to identify a cluster of interacting molecules
that tend to be collectively differentially expressed, and
therefore will reduce false positives. We used BioNet
[17, 18], a bioconductor package for the functional ana-
lysis of biological networks, which uses the p-values ob-
tained from differential expressed genes from RNA-seq
data. The goal of this algorithm is to identify functional
modules, or significantly differentially expressed subnet-
works, within large networks [17]. This was achieved
by computing a score for each node, reflected by its
p-value, and used a network search algorithm to find
the highest-scoring subgraph.
In this study, the maximally functional module was iden-
tified by computing optimal scores based on the p-values
from the RNA-seq data to evaluate how molecular activity
changes were correlated with rifampin regulation. False
discovery rate (FDR) is an adjustment parameter for con-
trolling the resultant subnetwork size. Since FDR can be
used for fine-tuning of the signal noise decomposition, we
scan a large range of FDRs and evaluate the obtained mod-
ules according to true-positive rate and precision (ratio of
true positives to all positively classify). As a result, a thresh-
old value of >0.0001 was used, because others thresholds
lead to either too small or too large size of the module.
The derived module captures the characteristically differ-
ently expressed interactions associated with rifampin treat-
ment. There were 84 genes and 89 interactions in the
maximally functional module. P-values, fold-changes, and
false discovery rates (FDR) for the genes of the maximally
functional module are shown in Additional file 1.
To avoid bias and to ensure generality of our results,
besides the maximally functional module, we identified
Table 2 Enrichment analysis of the maximally functional module in rifampin
DAVID (Term) Genes P-value
GO: Response to drug ABCB1,UGT1A4,CAV1,CAV2 3.6E-2
KEGG: Metabolism of xenobiotics by cytochrome P450 UGT1A4,ADH6,CYP1A1,CYP2C19,CYP2C9,CYP2E1 2.0E-4
KEGG: Retinol metabolism UGT1A4,ADH6,CYP1A1,CYP2C19,CYP2C9 1.4E-3
KEGG: Drug metabolism UGT1A4,ADH6, CYP2C19,CYP2C9,CYP2E1 2.4E-3
KEGG: Linoleic acid metabolism CYP2C19,CYP2C9,CYP2E1 2.7E-2
KEGG: Pathways in cancer CEBPA,CREBBP,SMAD3,TRAF2,BIRC3,EGLN2,FN1,IKBKG 2.9E-2
Focal adhesion BIRC3,CAV1,CAV2,FN1,ITGA1,THBS1 3.7E-2
Fig. 4 The pathway relative abundance of maximally functional module’s genes and all SDGs on the associated seven functional enrichment terms
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the multiple functional modules and key genes that also
demonstrated the significant enrichment on differentially
expressed genes; this analysis was done using the jActi-
veModules plug-in in cytoscape [15]. The maximum
depth from the start node was set as 2 and the overlap
threshold was set as 0. There were 31 nodes and 36 in-
teractions within the five functional modules. P-values,
Fold Changes, and false discovery rates (FDR) for the
genes within the five functional modules are shown in
Additional file 2. The maximally functional module and
five functional modules are shown in Fig. 3.
As expected, the results from BioNet are essentially in
agreement with the results from the jActiveModules
plug-in. The maximally functional module included all the
nodes and interactions of the five functional modules.
Enrichment analysis of functional modules
To systematically determine the roles of genes in the func-
tional modules, the online biological classification tool
DAVID was used to carry out the functional classification
based on GO and key signal pathways from KEGG. Since
most of the genes within the five modules were included
Fig. 5 The RrPIN extension network of 19 genes and associated 7 functions
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in the maximally functional module, we primarily focused
on the analysis of the maximally functional module. Table
of top 20 GO terms and top 10 KEGG terms for the genes
of functional modules were shown in Table 1. Due to the
redundant nature of the ontology analysis, functional an-
notation clustering was also derived from DAVID. A table
of the top 20 functional annotations clustering for the
genes of functional modules assessed by DAVID are pro-
vided in Additional file 3. Since the evidence suggests that
rifampin have a broad spectrum of effect on enhancing
drug metabolism, specifically, we focused on the GO
terms “drug” and “metabolism,” and the top six listed
KEGG pathways were extracted and the duplicates were
eliminated. The p-value was used to evaluate the signifi-
cance of the GO terms and KEGG pathways. Table 2
shows the results of the enrichment analysis of the max-
imally functional module in the RrPIN.
The results show that the maximally functional module
is relevant with seven functional enrichment terms: re-
sponse to drug, metabolism of xenobiotics by cytochrome
P450, retinol metabolism, drug metabolism, linoleic acid
metabolism, cancer pathways, and focal adhesion. Among
these terms, retinol metabolism, drug metabolism and
linoleic acid metabolism contained many similarities in
genes, since these three function terms were functionally
correlated and clustered in functional annotation clustering
in DAVID. In particular, the function pathways coincided
with previously reported rifampin-induced biological
functions. For example, rifampin affected the hepatic
drug disposition and metabolism [28, 29] and it was a
potent inducer of drug-metabolizing enzymes [6, 29–31].
Rifampin is also an inhibitor which rapidly downregulates
angiogenesis and mitogenesis-related genes to target
cancer cells [12, 32, 33].
In addition, we define the percentage of identified SDGs
in each pathway relative to the total number of SDGs as
pathway relative abundance. Assume that there are N
SDGs-associated biological pathways, for i–th pathway, S(i)
is number of identified SDGs, and N(i) is enriched number
of the total SDGs. The pathway relative abundance E(x) is
defined as:
E ið Þ ¼ S ið Þ
N ið Þ i∈1 ::N ð1Þ
Figure 4 shows the pathway relative abundance of max-
imally functional module’s genes and all SDGs on the as-
sociated seven functional enrichment terms. It can be
seen that the SDGs of maximally functional module are
more enriched and representative on each terms than the
total SDGs. This suggests that our strategy in integrating
PPI network with the differential expression analysis
helped us in capturing more biologically relevant signals.
To analyze each functional enrichment term, we focus
on the analysis of their genes. There were 19 key genes as-
sociated with 7 functions that we extracted using DAVID.
Then we extend the protein interaction network of 19
genes based on the RrPIN with one level interaction. The
RrPIN extension network of 19 genes consists of 50 nodes
and 53 interactions. The RrPIN extension network of 19
genes and associated 7 functions are shown as Fig. 5.
It is worth noting that UGT1A4, ADH6, CYP1A1,
CYP2C19, CYP2C9 and CYP2E1 are all associated with
metabolism of xenobiotics, drug metabolism, retinol
metabolism, and linoleic acid metabolism. BIRC3, CAV1,
CAV2, FN1, ITGA1 and THBS1 were functionally enriched
to focal adhesion, which contributes to antiangiogenic and
anti-tumour effects. These results indicate that rifampin in-
duced drug metabolism, partially, by regulating UGT1A4,
ADH6, CYP1A1, CYP2C19, CYP2C9 and CYP2E1. These
results also signify that rifampin can influence the anti-
angiogenesis and anti-tumour effects of drugs by regulating
BIRC3, CAV1, CAV2, FN1, ITGA1 and THBS1. Previ-
ous reports support these findings, stating that UGT1A4
CYP1A1, CYP2C19, CYP2C9 and CYP2E1 are drug-
metabolizing enzymes [34, 35], and ADH6 modulates
the risk for drug dependence [35]. BIRC3 contains anti-
apoptotic genes, which can be suppressed to counteract
cancerous activity [36]. CAV1 and CAV2 were correlated
with tumour growth and metastasis [37–39], and FN1
was a potential biomarker for some cancers [40, 41],
while ITGA1 and THBS1 were also associated with cancer
risk [42, 43].
In addition, some of the 19 key genes were hub pro-
teins that interacted with multiple proteins. For example,
CAV1, CREBBP, SMAD3, TRAF2, KBKG and THBS1
had at least four interactions with other proteins. These
results suggest that these six genes are important compo-
nents in biological pathways regulated by rifampin.
Table 3 The significant differentially expressed miRNAs
miRNA P-value miRNA P-value
Upregulated Upregulated
miR-886-3p 0.0002 miR-660 0.0297
miR-766 0.0075 miR-638 0.0302
miR-92a 0.0169 miR-25 0.0338
miR-107 0.0177 miR-616 0.0446
miR-30d# 0.0195 miR-576-3p 0.0453
miR-335 0.0241 miR-218 0.0499
Downregulated Downregulated
miR-186 0.0018 miR-320 0.0376
miR-361 0.0111 miR-202 0.0396
miR-95 0.0219 miR-200b# 0.0426
miR-345 0.0239 let-7 g 0.0435
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Joint analysis of key genes and associated miRNAs
To identify miRNAs that may regulate these key genes
within the functional modules, we correlated the alterations
in the miRNA and gene expression. In this process, we
extracted the significant differentially expressed miRNAs
(p < 0.05), and identified 20 miRNAs. The significant
differentially expressed miRNAs are shown in Table 3.
In order to identify the target genes of significant differ-
entially expressed miRNAs, three databases (Targetscan,
miRanda and PicTar) were used [20–23]. The miRNA-
mRNA pairs were extracted for each significant differ-
entially expressed miRNA. In order to include verified
miRNA-mRNA pairs, we also extracted the miRNA-
mRNA pairs from the miRTarBase [25, 26]. And the
miRNA-mRNA pairs of which mRNA is a gene of
maximally functional module were chosen. Then, we estab-
lished the miRNA-regulated PIN, which showed a negative
correlation between the miRNA and the mRNA. The
miRNA-regulated PIN, which is constructed of the genes in
the functional modules, is shown in Table 4 and Fig. 6.
Eight genes and 14 miRNAs were identified to have
significant differential expression changes. Each of these
genes was regulated by multiple miRNAs. Due to the
miRNAs control of gene expression, either by degrad-
ation of the target mRNAs or by inhibition of protein
translation, miRNA-regulated PPI networks can uncover
new rules of miRNA regulation or protein interaction.
Thus, we predicted the potential functions of miRNAs
based on the function of their target genes as shown in
Table 5.
Twelve miRNAs were extracted which associated with
6 biological pathways including response to drug, metab-
olism of xenobiotics by cytochrome P450, drug metabol-
ism, linoleic acid metabolism, cancer pathways, and
focal adhesion through regulation of 8 target genes. The
results suggest that miR-335 influences drug metabolism
through negative regulation of CYP2E1, which is a drug
metabolizing enzyme that is affected by rifampin treat-
ment. Therefore, it is possible that rifampin may alter
miRNA expression, which in turn affects the expression
of the drug metabolizing enzyme gene CYP2E1. MiR-
186 was found to regulate two genes (CEBPA, CREBBP),
which were associated with cancer pathways. MiR-186,
Fig. 6 The miRNA-regulated PIN which is constructed by the genes of functional modules
Table 4 The miRNA-regulated PIN which constructed by the
genes of functional modules
Gene list logFC miRNA P-value Fold change
CYP2E1 −1.4341 miR-335 0.0242 1.3300
CAV1 −0.8518 miR-34b 0.1753 185.3764
miR-886-3p 0.0001 1.5645
miR-218 0.0499 1.9012
miR-576-3p 0.0453 2.1916
CAV2 −0.5386 miR-200c 0.0913 4.8313
miR-576-3p 0.0453 2.1916
CEBPA 0.5812 miR-186 0.0017 0.8356
CREBBP 0.3821 miR-186 0.0017 0.8356
miR-95 0.0216 0.6320
miR-769 0.1249 0.8388
EGLN2 0.4574 miR-202 0.0396 0.5988
let-7 g 0.0435 0.8402
ITGA1 −0.3754 miR-616 0.0446 1.3337
miR-660 0.0297 1.2642
miR-576-3p 0.0453 2.1916
miR-335 0.0242 1.3300
THBS1 −0.3951 miR-886-3p 0.0001 1.5645
miR-335 0.0242 1.3300
miR-616 0.0446 1.3337
miR-92a 0.0169 1.1319
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miR-769, miR-95, miR-202 and let-7 g were also relevant
to cancer pathways, but did not serve other functions.
Previous studies have demonstrated that rifampin also
inhibited anti-angiogenesis by regulating the expression of
multiple miRNAs (miR-34b, miR-886-3p, miR-218, miR-
576-3p, miR-200c, miR-616, miR-660, miR-335, miR-92a),
and further induced the gene expression of BIRC3, CAV1,
CAV2, FN1, ITGA1 and THBS1.
Conclusions
In conclusion, a novel integrative network-based method
was used to identify the functional modules and discover
the potential functions of miRNAs based on human pro-
tein network, mRNA and miRNA expression profile in
rifampin treated hepatocytes. Furthermore, this method
identifies 19 genes and 7 crucial biological pathways. By
analysing the miRNA-regulated PIN, we suggested that
12 miRNAs were associated with 6 biological pathways
through regulation of 8 target genes. Our results suggest
that rifampin contributes to changes in the expression of
genes and miRNAs, and induces multiple biological
pathways. This study not only provides an insight into
functional modules that are associated with rifampin-
treated human hepatocytes in human protein interaction
network, it also shows that the integrated analysis of
mRNA, miRNA expression profile and PIN can be used
to study the molecular mechanism of rifampin-induced
drug disposition.
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